Prana recruiting for Alzheimer's drug trial

12/15/2011 | MarketWire

Prana Biotechnology said it has started screening patient participants for a Phase II imaging trial of its experimental Alzheimer's disease drug PBT2. The trial will use PiB-PET imaging and blood tests to determine the effects of the drug.

View Full Article in:

MarketWire

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA